Original Versus Generic Eltrombopag in Patients with Immune Thrombocytopenia: A Prospective Multi-Center Experience on Efficacy and Safety.

J Clin Med · 2026 · PMC12841940 · PMID 41598573

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In the RAISE study, although improvements in FACIT-Fatigue scores were observed in the eltrombopag arm, the difference between groups did not reach statistical significance [ 6 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.